Core Viewpoint - Duori Pharmaceutical (301075.SZ) is currently in negotiations regarding a transaction, with no formal agreement signed yet, leading to an expected continuation of stock suspension until at least October 9, 2025 [1] Summary by Relevant Sections - Transaction Status - The parties involved are actively advancing the transaction, but the overall plan is still under negotiation [1] - No formal agreement has been reached as of the announcement date [1] - Stock Suspension - The company anticipates that it will not resume trading on October 9, 2025, at the market opening [1] - Due to the uncertainties surrounding the transaction, the company has applied for an extension of the stock suspension, which is expected to last no more than three trading days [1]
多瑞医药(301075.SZ)：股票继续停牌，预计停牌时间不超过3个交易日